Exploration of helminth-derived immunoregulatory molecules as options for therapeutic intervention in allograft rejection and autoimmune disease
dc.contributor.advisor
Maizels, Rick
en
dc.contributor.advisor
Wigmore, Stephen
en
dc.contributor.advisor
Anderton, Stephen
en
dc.contributor.author
Johnston, Christopher John Cyril
en
dc.contributor.sponsor
Wellcome Trust
en
dc.date.accessioned
2016-11-22T10:47:13Z
dc.date.available
2016-11-22T10:47:13Z
dc.date.issued
2016-06-28
dc.description.abstract
Solid organ transplantation is the gold standard treatment for a variety of conditions
that result in organ failure. However, despite considerable advances in clinical
transplantation in recent decades, the almost ubiquitous requirement of life-long
immunosuppression of transplant recipients persists and is complicated by graft loss
to rejection in the long term and multiple serious adverse effects that are frequently
life limiting.
Helminths currently infect more than one quarter of the world’s population and it is
now well established that their success as parasites is the result of active
immunomodulation of the host immune response. Whilst this primarily secures ongoing
survival of the parasites, in some cases helminth-induced immunomodulation
can be beneficial to the infected host and is not associated with the adverse sequelae
of pharmacological immunosuppression. An emerging body of evidence suggests
that harmful immune responses to alloantigens can be suppressed by helminths, but
little mechanistic data exists and the active immunomodulators involved have
remained hitherto unidentified.
The hypothesis behind this thesis is that the model intestinal nematode,
Heligmosomoides polygyrus, produces immunomodulatory molecules that can
suppress responses to allo- and auto-antigens in animal models of transplantation and
autoimmunity, and that some of these molecules could potentially be exploited as
novel therapeutic agents.
Full-thickness skin grafting was performed between fully-allogeneic mouse strains
(BALB/c to C57BL/6). Recipient mice infected with H. polygyrus immediately prior
to transplantation showed significantly prolonged allograft survival. Likewise,
protection from allograft rejection could be replicated in recipient mice in which H.
polygyrus excretory-secretory products (HES) (isolated from culture of adult worms)
were delivered by continuous infusion via surgically implanted osmotic minipumps.
A number of potential mechanisms underlying allograft protection were identified
including induction of CD4+CD25+Foxp3+ regulatory T cells (Treg) and suppression
of Th1 and Th17 effector CD4+ T cell phenotypes.
H. polygyrus and HES were further shown to ameliorate disease in murine (pMOG)
experimental autoimmune encephalomyelitis and colitis induced by T cell transfer. In
addition to expansion of Treg, H. polygyrus-mediated protection against EAE was
found to be almost completely lost in IL-4 receptor deficient mice, indicating a
protective role of Th2 immune responses in this context.
Finally, the mechanisms of action of the newly-identified TGF-β mimic, TGM,
contained within HES were investigated. Despite bearing no sequence homology or
structural resemblance to TGF-β, TGM was shown to act through the TGF-β receptor
complex to induce Treg in human and mouse CD4+ T cells in vitro and to suppress
murine allogeneic skin graft rejection in vivo. TGM may represent the origin of a
safe, effective and long-overdue novel alternative to current immunosuppression
therapy.
en
dc.identifier.uri
http://hdl.handle.net/1842/17936
dc.language.iso
en
dc.publisher
The University of Edinburgh
en
dc.relation.hasversion
Johnston CJ, Robertson E, Harcus Y, Grainger JR, Coakley G, Smyth DJ, McSorley HJ, Maizels R. Cultivation of Heligmosomoides polygyrus: an immunomodulatory nematode parasite and its secreted products. J Vis Exp. 2015(98):e52412.
en
dc.relation.hasversion
Chris J.C. Johnston, Henry J. McSorley, Stephen M. Anderton, Stephen J. Wigmore, and Rick M. Maizels, 'Helminths and Immunological Tolerance', Transplantation 2014;97: 127Y132
en
dc.relation.hasversion
Chris J.C. Johnston, Danielle J. Smyth, David W. Dresser, Rick M. Maizels, 'TGF-b in tolerance, development and regulation of immunity', Cellular Immunology 299 (2016) 14–22.
en
dc.subject
transplant
en
dc.subject
allograft
en
dc.subject
helminth
en
dc.subject
EAE
en
dc.subject
Heligmosomoides polygyrus
en
dc.title
Exploration of helminth-derived immunoregulatory molecules as options for therapeutic intervention in allograft rejection and autoimmune disease
en
dc.type
Thesis or Dissertation
en
dc.type.qualificationlevel
Doctoral
en
dc.type.qualificationname
PhD Doctor of Philosophy
en
Files
Original bundle
1 - 1 of 1
- Name:
- Johnston2016.pdf
- Size:
- 34.16 MB
- Format:
- Adobe Portable Document Format
This item appears in the following Collection(s)

